Xellar raised a $50M Series A to build its 3D bio intelligence platform.
- Amount
- $50M
- Stage
- Series A
- Announced
- 29 June 2026
- Use of funds
- Expand automated biological data generation capabilities, strengthen AI and computational biology teams, accelerate virtual cell technologies.
- Checked
- Amount and date checked against the press source